| Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli M Di Nicola, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, ... Blood, The Journal of the American Society of Hematology 99 (10), 3838-3843, 2002 | 4354 | 2002 |
| High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma AM Gianni, M Bregni, S Siena, C Brambilla, M Di Nicola, F Lombardi, ... New England Journal of Medicine 336 (18), 1290-1298, 1997 | 647 | 1997 |
| Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis C Gambacorti-Passerini, P Le Coutre, L Mologni, M Fanelli, C Bertazzoli, ... Blood Cells, Molecules, and Diseases 23 (3), 380-394, 1997 | 458 | 1997 |
| A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus–associated lymphoid malignancies SP Perrine, O Hermine, T Small, F Suarez, R O'Reilly, F Boulad, ... Blood 109 (6), 2571-2578, 2007 | 322 | 2007 |
| Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion M Magni, M Di Nicola, L Devizzi, P Matteucci, F Lombardi, L Gandola, ... Blood, The Journal of the American Society of Hematology 96 (3), 864-869, 2000 | 306 | 2000 |
| Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy. S Siena, M Di Nicola, M Bregni, R Mortarini, A Anichini, L Lombardi, ... Experimental hematology 23 (14), 1463-1471, 1995 | 298 | 1995 |
| Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen) AM Gianni, M Magni, M Martelli, M Di Nicola, C Carlo-Stella, S Pilotti, ... Blood 102 (2), 749-755, 2003 | 289 | 2003 |
| An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide … A Anichini, A Molla, R Mortarini, G Tragni, I Bersani, M Di Nicola, ... The Journal of experimental medicine 190 (5), 651-668, 1999 | 228 | 1999 |
| Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year … AM Gianni, S Siena, M Bregni, M Di Nicola, S Orefice, F Cusumano, ... Journal of clinical oncology 15 (6), 2312-2321, 1997 | 220 | 1997 |
| Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients L Passoni, L Longo, P Collini, AML Coluccia, F Bozzi, M Podda, ... Cancer research 69 (18), 7338-7346, 2009 | 213 | 2009 |
| Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in … C Tarella, R Passera, M Magni, F Benedetti, A Rossi, A Gueli, C Patti, ... Journal of Clinical Oncology 29 (7), 814-824, 2011 | 176 | 2011 |
| WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer L Castagnoli, V Cancila, SL Cordoba-Romero, S Faraci, G Talarico, ... Oncogene 38 (21), 4047-4060, 2019 | 167 | 2019 |
| Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer M Bregni, M Magni, S Siena, M Di Nicola, G Bonadonna, AM Gianni Blood 80 (6), 1418-1422, 1992 | 162 | 1992 |
| Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a … M Di Nicola, R Zappasodi, C Carlo-Stella, R Mortarini, SM Pupa, M Magni, ... Blood, The Journal of the American Society of Hematology 113 (1), 18-27, 2009 | 154 | 2009 |
| Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death R Zappasodi, SM Pupa, GC Ghedini, I Bongarzone, M Magni, AD Cabras, ... Cancer research 70 (22), 9062-9072, 2010 | 151 | 2010 |
| Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in second-line treatment of patients with NSCLC: results from an expansion cohort of a phase 1 trial L Paz-Ares, TM Kim, D Vicente, E Felip, DH Lee, KH Lee, CC Lin, MJ Flor, ... Journal of Thoracic Oncology 15 (7), 1210-1222, 2020 | 144 | 2020 |
| Antitumor vaccination: where we stand M Bocchia, V Bronte, MP Colombo, A De Vincentiis, M Di Nicola, G Forni, ... Haematologica 85 (11), 1172-1206, 2000 | 133 | 2000 |
| Autologous Dendritic Cells Derived from CD34+ Progenitors and from Monocytes Are Not Functionally Equivalent Antigen-presenting Cells in the Induction of Melan-A/Mart-1 … R Mortarini, A Anichini, M Di Nicola, S Siena, M Bregni, F Belli, A Molla, ... Cancer research 57 (24), 5534-5541, 1997 | 132 | 1997 |
| High doses of antimetabolites followed by high-dose sequential chemoimmunotherapy and autologous stem-cell transplantation in patients with systemic B-cell lymphoma and … AJM Ferreri, G Donadoni, MG Cabras, C Patti, M Mian, R Zambello, ... Journal of Clinical Oncology 33 (33), 3903-3910, 2015 | 124 | 2015 |
| Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells HM Bond, M Mesuraca, E Carbone, P Bonelli, V Agosti, N Amodio, ... Blood 103 (6), 2062-2070, 2004 | 109 | 2004 |
